LI
RCKT icon

Leap Investments’s Rocket Pharmaceuticals RCKT Stock Holding History

Leap Investments’s Portfolio RCKT Stock Details RCKT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$211K Buy
+10,100
New +$182K 0.14% 286

Other funds holding RCKT

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Leap Investments's RCKT Position: Q2 2020 in Review

Leap Investments opened a new position in Rocket Pharmaceuticals (RCKT) in Q2 2020: 10,100 shares worth $211K. The stake represents 0.14% of the portfolio and ranks #286 among its holdings.

119 funds tracked by Wall St. Rank hold RCKT as of Q2 2020.

  • Leap Investments held 10,100 shares of Rocket Pharmaceuticals worth $211K as of Q2 2020.
  • Rocket Pharmaceuticals was a new Leap Investments position in Q2 2020.
  • Rocket Pharmaceuticals made up 0.14% of Leap Investments's portfolio in Q2 2020, its #286 holding.
  • 119 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.